Pharvaris president sells 100K shares at $35

Pharvaris N.V.’s president exercised 100,000 options and sold the resulting shares in a same‑day transaction.

Rhea-AI Filing Summary

Pharvaris N.V. (PHVS) reported that President Lu Peng exercised stock options and sold shares on September 17, 2026. Options for 100,000 shares of common stock were exercised at an exercise price of $2.59 per share, and the resulting 100,000 shares of common stock were then sold at $35.00 per share. No Rule 10b5-1 trading plan is reported for these transactions.

Insider Trade Summary

Exercise and Sale: 100,000 shares ($3.24M approx. pre-tax spread)

Exercise and Sale 4 txns

Insider Lu Peng

Role President

Sold 100,000 shs ($3.50M)

Approx. gross sale proceeds $3.50M

Approx. exercise cost $259K

Approx. pre-tax spread $3.24M

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy) F1	13,308	$0.00	$0.00
Exercise	Stock Option (Right to Buy) F1	86,692	$0.00	$0.00
Exercise	Common Stock	100,000	$2.59	$259K
Sale	Common Stock	100,000	$35.00	$3.50M

Holdings After Transaction: Stock Option (Right to Buy) — 45,308 contracts (Direct); Common Stock — 64,953 shares (Direct)

Footnotes (1)

1. F1. 25% of the option vested on February 3, 2021 with the remaining shares vesting in 1/48 monthly installments thereafter.

Key Figures

Shares sold: 100,000 shares Sale price: $35.00 per share Options exercised: 100,000 shares +2 more

5 metrics

Shares sold 100,000 shares Common stock sold by Lu Peng on September 17, 2026

Sale price $35.00 per share Price for 100,000 common shares sold on September 17, 2026

Options exercised 100,000 shares Underlying common shares from stock options exercised on September 17, 2026

Exercise price $2.59 per share Exercise price for stock options converted into 100,000 common shares

Option expiration 2030 Expiration years of the exercised stock options (February 3, 2030 and March 3, 2030)

Key Terms

Stock Option (Right to Buy), derivative security, vesting

3 terms

Stock Option (Right to Buy) financial

"The security is listed as Stock Option (Right to Buy) with an exercise price."

derivative security financial

"The option transactions are classified as a derivative security exercise."

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

vesting financial

"25% of the option vested on February 3, 2021 with remaining shares vesting monthly."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Pharvaris N.V. (PHVS) disclose about Lu Peng’s recent equity transactions?

Pharvaris N.V. disclosed that President Lu Peng exercised options for 100,000 shares of common stock at $2.59 per share and sold the resulting 100,000 shares at $35.00 per share on September 17, 2026.

How many PHVS shares did Lu Peng sell in this Form 4 filing?

Lu Peng sold 100,000 shares of Pharvaris N.V. common stock at a price of $35.00 per share on September 17, 2026, following the exercise of stock options for the same number of shares at an exercise price of $2.59.

At what prices were Lu Peng’s PHVS option exercise and share sale reported?

The stock options were exercised at an exercise price of $2.59 per share, creating 100,000 shares of common stock, which were then sold at $35.00 per share in a same‑day transaction.

Were Lu Peng’s PHVS transactions under a Rule 10b5-1 trading plan?

No. The filing indicates that the Rule 10b5-1 checkbox is not affirmed, and there is no footnote stating that the September 17, 2026 transactions were made under a Rule 10b5-1 or other pre‑arranged trading plan.

What option terms were disclosed for Lu Peng’s PHVS stock options?

Two stock option positions, each labeled Stock Option (Right to Buy), were exercised for a combined 100,000 underlying shares of common stock at an exercise price of $2.59 per share, with expiration dates in 2030 and vesting described as monthly after an initial 25% vest.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/21/2026 - 04:22 PM Accepted by SEC EDGAR 09/21/2026 - 04:20 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lu Peng

(Last) (First) (Middle)

1 CRANBERRY HILL SUITE 400

(Street)

LEXINGTON MASSACHUSETTS 02421

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Pharvaris N.V. [ PHVS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/17/2026		M		100,000	A	$2.59	164,953	D
Common Stock	09/17/2026		S		100,000	D	$35	64,953	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$2.59	09/17/2026		M			13,308	(1)	02/03/2030	Common Stock	13,308	$0	0	D
Stock Option (Right to Buy)	$2.59	09/17/2026		M			86,692	(1)	03/03/2030	Common Stock	86,692	$0	45,308	D

Explanation of Responses:

1. 25% of the option vested on February 3, 2021 with the remaining shares vesting in 1/48 monthly installments thereafter.

	/s/ Marnus Nel, Attorney-in-Fact for Peng Lu	09/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)